{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:35:33Z","timestamp":1792701333384,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.omtn.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T20:38:45Z","timestamp":1674247125000},"page":"370-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5032-0729","authenticated-orcid":false,"given":"Amy D.","family":"Gelinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiong Kit","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier G.","family":"Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam C.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Ream","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea N.","family":"Chase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Otis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6811-167X","authenticated-orcid":false,"given":"Nebojsa","family":"Janjic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2023.01.008_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.01.008_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.omtn.2023.01.008_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.omtn.2023.01.008_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.01.008_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.01.008_bib6","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.01.008_bib7","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2023.01.008_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2023.01.008_bib9","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","author":"Wrapp","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2023.01.008_bib10","doi-asserted-by":"crossref","first-page":"e1004502","DOI":"10.1371\/journal.ppat.1004502","article-title":"Coronavirus cell entry occurs through the endo-\/lysosomal pathway in a proteolysis-dependent manner","volume":"10","author":"Burkard","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2023.01.008_bib11","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.01.008_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtn.2023.01.008_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.01.008_bib14","series-title":"Tracking SARS-CoV-2 Variants, 2021","author":"Organization","year":"2021"},{"key":"10.1016\/j.omtn.2023.01.008_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.omtn.2023.01.008_bib16","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.sbi.2016.01.009","article-title":"Embracing proteins: structural themes in aptamer-protein complexes","volume":"36","author":"Gelinas","year":"2016","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.omtn.2023.01.008_bib17","doi-asserted-by":"crossref","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2023.01.008_bib18","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1021\/ja908035g","article-title":"Expanding the chemistry of DNA for in\u00a0vitro selection","volume":"132","author":"Vaught","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2023.01.008_bib19","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1073\/pnas.1615475114","article-title":"Selection of DNA aptamers with two modified bases","volume":"114","author":"Gawande","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2023.01.008_bib20","doi-asserted-by":"crossref","first-page":"12692","DOI":"10.1128\/JVI.77.23.12692-12698.2003","article-title":"Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers","volume":"77","author":"Khati","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2023.01.008_bib21","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1261\/rna.7205405","article-title":"Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1","volume":"11","author":"Dey","year":"2005","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2023.01.008_bib22","doi-asserted-by":"crossref","first-page":"13806","DOI":"10.1128\/JVI.79.21.13806-13810.2005","article-title":"An aptamer that neutralizes R5 strains of human immunodeficiency virus type 1 blocks gp120-CCR5 interaction","volume":"79","author":"Dey","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2023.01.008_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2008.08.025","article-title":"An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site","volume":"381","author":"Cohen","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2023.01.008_bib24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.omtn.2023.01.008_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.01.008_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2023.01.008_bib27","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1074\/jbc.M113.532580","article-title":"Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor","volume":"289","author":"Gupta","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omtn.2023.01.008_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/nat.2015.0573","article-title":"Fit for the eye: aptamers in ocular disorders","volume":"26","author":"Drolet","year":"2016","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtn.2023.01.008_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.omtn.2023.01.008_bib30","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1021\/jo00408a041","article-title":"Rapid chromatographic technique for preparative separations with moderate resolution","volume":"43","author":"Still","year":"1978","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.omtn.2023.01.008_bib31","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/nar\/25.14.2784","article-title":"Site-specific introduction of functional groups into phosphodiester oligodeoxynucleotides and their thermal stability and nuclease-resistance properties","volume":"25","author":"Nomura","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2023.01.008_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/15257770.2014.978011","article-title":"Practical synthesis of cytidine-5-carboxamide-modified nucleotide reagents","volume":"34","author":"Rohloff","year":"2015","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.omtn.2023.01.008_bib33","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0040-4039(01)90461-7","article-title":"Deoxynucleoside phosphoramidites-a new class of key intermediates for deoxypolynucleotide synthesis","volume":"22","author":"Beaucage","year":"1981","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.omtn.2023.01.008_bib34","doi-asserted-by":"crossref","first-page":"e1009352","DOI":"10.1371\/journal.ppat.1009352","article-title":"Breadth and function of antibody response to acute SARS-CoV-2 infection in humans","volume":"17","author":"Huang","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtn.2023.01.008_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.celrep.2019.03.020","article-title":"Therapeutic monoclonal antibodies for ebola virus infection derived from vaccinated humans","volume":"27","author":"Rijal","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2023.01.008_bib36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","article-title":"A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2023.01.008_bib37","article-title":"Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes","author":"Fan","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2023.01.008_bib38","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2023.01.008_bib39","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1021\/pr101065j","article-title":"Andromeda: a peptide search engine integrated into the MaxQuant environment","volume":"10","author":"Cox","year":"2011","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.omtn.2023.01.008_bib40","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1021\/acs.analchem.0c05045","article-title":"Improving spectral validation rates in hydrogen-deuterium exchange data analysis","volume":"93","author":"Raval","year":"2021","journal-title":"Anal. Chem."},{"key":"10.1016\/j.omtn.2023.01.008_bib41","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.str.2014.08.013","article-title":"Mass spec studio for integrative structural biology","volume":"22","author":"Rey","year":"2014","journal-title":"Structure"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123000112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253123000112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:33:53Z","timestamp":1761874433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253123000112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":41,"alternative-id":["S2162253123000112"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2023.01.008","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}]}}